Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
grade B 26.205 0.40% 0.11
NTRA closed down 0.87 percent on Friday, July 19, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NTRA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.40%
Bollinger Band Squeeze Range Contraction 0.40%
Crossed Above 20 DMA Bullish -0.47%
Pocket Pivot Bullish Swing Setup -0.47%
Bollinger Band Squeeze Range Contraction -0.47%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.64%
Spinning Top Other 2.64%
Bollinger Band Squeeze Range Contraction 2.64%
Stochastic Reached Oversold Weakness 2.64%
Inside Day Range Contraction 2.64%

Older signals for NTRA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Medicine Clinical Medicine Medical Genetics Medical Tests Applied Genetics DNA Genetic Testing DNA Paternity Testing In Vitro Fertilization Severe Genetic Diseases
Is NTRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 29.62
52 Week Low 11.08
Average Volume 695,797
200-Day Moving Average 19.1925
50-Day Moving Average 24.4956
20-Day Moving Average 26.1435
10-Day Moving Average 25.96
Average True Range 1.0273
ADX 24.04
+DI 22.54
-DI 14.2171
Chandelier Exit (Long, 3 ATRs ) 24.8881
Chandelier Exit (Short, 3 ATRs ) 27.1919
Upper Bollinger Band 27.6069
Lower Bollinger Band 24.6801
Percent B (%b) 0.49
BandWidth 11.195135
MACD Line 0.3904
MACD Signal Line 0.5827
MACD Histogram -0.1923
Fundamentals Value
Market Cap 1.39 Billion
Num Shares 53.2 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -10.74
Price-to-Sales 2.91
Price-to-Book 11.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.35
Resistance 3 (R3) 27.47 27.17 27.14
Resistance 2 (R2) 27.17 26.86 27.11 27.07
Resistance 1 (R1) 26.64 26.66 26.49 26.52 27.00
Pivot Point 26.34 26.34 26.27 26.28 26.34
Support 1 (S1) 25.81 26.03 25.66 25.69 25.20
Support 2 (S2) 25.51 25.83 25.45 25.13
Support 3 (S3) 24.98 25.51 25.06
Support 4 (S4) 24.86